Showing results (611-620 of 1,007) with videos related to

Sort By:
Pageof 101
Thrombosis Journal|November 19, 2015
Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trialsBengt I Eriksson, Ola E Dahl, Nadia Rosencher, et al.
Thrombosis Journal|September 8, 2017
Dabigatran reversal with idarucizumab in a patient undergoing heart transplantation: first European reportAntónio Tralhão, Carlos Aguiar, Jorge Ferreira, et al.
Thrombosis Journal|September 23, 2017
The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patientsDaniel Jones, Kurt Wismayer, George Bozas, et al.
Thrombosis Journal|March 7, 2018
Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!Hikmat Abdel-Razeq, Asem Mansour, Hazem Abdulelah, et al.
Thrombosis Journal|December 12, 2018
Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I studyDagmar Kubitza, Stefan Willmann, Michael Becka, et al.
Thrombosis Journal|March 24, 2018
Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrelSatoshi Niijima, Tsukasa Ohmori, Kazuomi Kario
Thrombosis Journal|January 18, 2019
Circulating histone H3 levels in septic patients are associated with coagulopathy, multiple organ failure, and death: a single-center observational studyYayoi Yokoyama, Takashi Ito, Tomotsugu Yasuda, et al.
Thrombosis Journal|October 3, 2008
A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalanceKim Frederix, Ingeborg M Kooter, René van Oerle, et al.
Thrombosis Journal|September 26, 2007
Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole bloodChristoph Sucker, Kai Zacharowski, Matthias Thielmann, et al.
Thrombosis Journal|November 21, 2007
Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stentingClaire Le Hello, Rémy Morello, Agnès Lequerrec, et al.
Pageof 101